Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filings, submissions and communications with Regulatory Authorities regarding such Party’s Molecule.
Appears in 4 contracts
Samples: Combination Study Agreement (Corvus Pharmaceuticals, Inc.), Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.), Ib Combination Study Agreement (Corvus Pharmaceuticals, Inc.)
Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filings, submissions and communications with Regulatory Authorities regarding such Party’s MoleculeCompound.
Appears in 3 contracts
Samples: Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc)
Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to a Regulatory Authorities Authority to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filingsto conduct preclinical or clinical studies related to its Collaboration Compounds or Licensed Products, submissions and communications with Regulatory Authorities regarding such Party’s Molecule.other compounds that meet the Compound Criteria for, and are directed to, its Draft Pick Targets, and related Companion Diagnostics. CONFIDENTIAL EXECUTION VERSION
Appears in 3 contracts
Samples: License and Collaboration Agreement (Constellation Pharmaceuticals Inc), License and Collaboration Agreement (Constellation Pharmaceuticals Inc), License and Collaboration Agreement (Constellation Pharmaceuticals Inc)
Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities Information to the extent such disclosure is required to comply with applicable governmental regulations regulations, to conduct preclinical or is Clinical Studies related to Collaboration Products in connection accordance with such the terms of this Agreement, or, with respect to any Lead Regulatory Party’s filings, submissions and communications to obtain Regulatory Approval of Collaboration Products in accordance with Regulatory Authorities regarding such Party’s Moleculethe terms of this Agreement.
Appears in 2 contracts
Samples: Collaboration Agreement (BioNTech SE), Collaboration Agreement (BioNTech SE)
Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to a Regulatory Authorities Authority to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filings, submissions and communications with Regulatory Authorities regarding such Party’s Moleculeto conduct preclinical or clinical studies related to Ligand Traps.
Appears in 2 contracts
Samples: Research Collaboration and Exclusive License Agreement (Keros Therapeutics, Inc.), Research Collaboration and Exclusive License Agreement (Keros Therapeutics, Inc.)
Regulatory Authorities. A The Receiving Party may disclose the other Disclosing Party’s Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities to the extent such disclosure is required to comply with applicable governmental regulations Applicable Laws or is in connection with such Party’s regulatory filings, submissions and communications with Regulatory Authorities regarding such Party’s MoleculeProduct.
Appears in 2 contracts
Samples: Collaboration Agreement (Affimed N.V.), Collaboration Agreement (Affimed N.V.)
Regulatory Authorities. A Party may disclose the other Party’s Joint Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filings, submissions and communications with Regulatory Authorities regarding such Party’s MoleculeInvestigational Product; provided, however, such Party shall provide written notice to the other Party of such Party’s anticipated use of the Joint Confidential Information in a timely manner prior to such anticipated use.
Appears in 1 contract
Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filings, submissions and communications with Regulatory Authorities regarding such Party’s Moleculeto conduct preclinical or clinical trials related to Licensed Products.
Appears in 1 contract
Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filings, submissions and communications with Regulatory Authorities regarding such Party’s MoleculeCompound.
Appears in 1 contract
Samples: Ii Combination Study Agreement (Corvus Pharmaceuticals, Inc.)
Regulatory Authorities. A Party may disclose the other Party’s Confidential Information or Joint Confidential Information, as the case may be, to Regulatory Authorities to the extent such disclosure is required to comply with applicable governmental regulations or is in connection with such Party’s filings, submissions and communications with Regulatory Authorities regarding such Party’s MoleculeCompound, the Combination or the Study.
Appears in 1 contract
